Article info
PDFOriginal article
LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma
- Correspondence to Professor Dr Alexandar Tzankov, Institute of Pathology, Schönbeinstrasse 40, Basel 4031, Switzerland; alexandar.tzankov{at}usb.ch
Citation
LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma
Publication history
- Received January 5, 2015
- Revised February 2, 2015
- Accepted February 5, 2015
- First published February 24, 2015.
Online issue publication
August 11, 2020
Article Versions
- Previous version (15 June 2020).
- Previous version (15 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions